Chen Y, Reddy S, Suzuki A
Life Sci Alliance. 2025; 8(5).
PMID: 40037894
PMC: 11880160.
DOI: 10.26508/lsa.202403000.
Pan Q, Luo P, Qiu Y, Hu K, Lin L, Zhang H
Cell Death Differ. 2025; .
PMID: 40016337
DOI: 10.1038/s41418-025-01465-z.
Chen Y, Chen Y, Suzuki A
J Cell Sci. 2024; 137(22).
PMID: 39564775
PMC: 11607684.
DOI: 10.1242/jcs.263414.
Chen Y, Chen Y, Suzuki A
bioRxiv. 2024; .
PMID: 39185179
PMC: 11343203.
DOI: 10.1101/2024.08.14.607961.
Figarol S, Delahaye C, Gence R, Doussine A, Cerapio J, Brachais M
Nat Commun. 2024; 15(1):5345.
PMID: 38937474
PMC: 11211478.
DOI: 10.1038/s41467-024-49360-4.
Transcriptome-Wide N6-Methyladenosine Alternations in Pulmonary Arteries of Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats and Novel Therapeutic Targets.
Feng Y, Yu Z, Tang M, Li J, Peng B, Juaiti M
Biomedicines. 2024; 12(2).
PMID: 38397966
PMC: 10886831.
DOI: 10.3390/biomedicines12020364.
The fine-scale recombination rate variation and associations with genomic features in a butterfly.
Palahi I Torres A, Hook L, Nasvall K, Shipilina D, Wiklund C, Vila R
Genome Res. 2023; 33(5):810-823.
PMID: 37308293
PMC: 10317125.
DOI: 10.1101/gr.277414.122.
Deciphering the Prognostic and Therapeutic Significance of Cell Cycle Regulator CENPF: A Potential Biomarker of Prognosis and Immune Microenvironment for Patients with Liposarcoma.
Chen J, Lian Y, Zhao B, Han J, Li X, Wu J
Int J Mol Sci. 2023; 24(8).
PMID: 37108172
PMC: 10139200.
DOI: 10.3390/ijms24087010.
Genome-Wide Association Study of Egg-Laying Traits and Egg Quality in LingKun Chickens.
Gao J, Xu W, Zeng T, Tian Y, Wu C, Liu S
Front Vet Sci. 2022; 9:877739.
PMID: 35795788
PMC: 9251537.
DOI: 10.3389/fvets.2022.877739.
Protein Farnesylation on Nasopharyngeal Carcinoma, Molecular Background and Its Potential as a Therapeutic Target.
Kobayashi E, Kondo S, Dochi H, Moriyama-Kita M, Hirai N, Komori T
Cancers (Basel). 2022; 14(12).
PMID: 35740492
PMC: 9220992.
DOI: 10.3390/cancers14122826.
CENPF/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2/M-phase cell cycle.
Huang Y, Li D, Wang L, Su X, Tang X
J Transl Med. 2022; 20(1):78.
PMID: 35123514
PMC: 8818156.
DOI: 10.1186/s12967-022-03277-y.
Potential of Farnesyl Transferase Inhibitors in Combination Regimens in Squamous Cell Carcinomas.
Kessler L, Malik S, Leoni M, Burrows F
Cancers (Basel). 2021; 13(21).
PMID: 34771475
PMC: 8582567.
DOI: 10.3390/cancers13215310.
Apoptosis-induced translocation of centromere protein F in its corresponding autoantibody production in hepatocellular carcinoma.
Li X, Li Y, Xu A, Zhou D, Zhang B, Qi S
Oncoimmunology. 2021; 10(1):1992104.
PMID: 34676150
PMC: 8525945.
DOI: 10.1080/2162402X.2021.1992104.
Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer models.
Coulson-Gilmer C, Morgan R, Nelson L, Barnes B, Tighe A, Wardenaar R
J Exp Clin Cancer Res. 2021; 40(1):323.
PMID: 34656146
PMC: 8520217.
DOI: 10.1186/s13046-021-02124-0.
TP53 loss initiates chromosomal instability in fallopian tube epithelial cells.
Bronder D, Tighe A, Wangsa D, Zong D, Meyer T, Wardenaar R
Dis Model Mech. 2021; 14(11).
PMID: 34569598
PMC: 8649171.
DOI: 10.1242/dmm.049001.
Baricitinib, a JAK-STAT Inhibitor, Reduces the Cellular Toxicity of the Farnesyltransferase Inhibitor Lonafarnib in Progeria Cells.
Arnold R, Vehns E, Randl H, Djabali K
Int J Mol Sci. 2021; 22(14).
PMID: 34299092
PMC: 8307450.
DOI: 10.3390/ijms22147474.
Centromere Protein F () Serves as a Potential Prognostic Biomarker and Target for Human Hepatocellular Carcinoma.
Huang Y, Chen X, Wang L, Wang T, Tang X, Su X
J Cancer. 2021; 12(10):2933-2951.
PMID: 33854594
PMC: 8040902.
DOI: 10.7150/jca.52187.
Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
Li M, Zhang M, Dong H, Li A, Teng H, Liu A
Int J Med Sci. 2021; 18(2):494-504.
PMID: 33390818
PMC: 7757141.
DOI: 10.7150/ijms.49041.
Loss of CENPF leads to developmental failure in mouse embryos.
Zhou C, Wang X, Han Z, Wang D, Ma Y, Liang C
Cell Cycle. 2019; 18(20):2784-2799.
PMID: 31478449
PMC: 6773247.
DOI: 10.1080/15384101.2019.1661173.
DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors.
Pillay N, Tighe A, Nelson L, Littler S, Coulson-Gilmer C, Bah N
Cancer Cell. 2019; 35(3):519-533.e8.
PMID: 30889383
PMC: 6428690.
DOI: 10.1016/j.ccell.2019.02.004.